… and serosal invasion of primary colorectal cancers [21], … skin melanoma (NCT02993315)
and uveal melanoma [26] are ongoing. Our study chose resectable metastatic colon cancer …

… that autologous tumor lysate–pulsed dendritic cell (DC) … the third vaccination with the lysate,
MesoPher, tumor lysate–pulsed … a MAGE antigen–expressing colorectal cancer patient (30). …

… immunized patients with metastatic colorectal cancer with 1 × … Patients received 3 successive
injections with 1 × 10 6 CEA-… cancers may not function as effectively as in melanoma and …

… lysate-pulsed DCs vaccine as intradermal injections in the … of 5 patients with stage D 3
patients advanced to stage B and … Dendritic cell vaccination for metastatic melanoma: a 14-year …

… Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat …
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: …

… melanoma cell lysate expressing at least one of six MAGE-A antigens were examined in this
phase II study[… long peptide vaccine in patients treated for metastatic colorectal cancer. Clin …

… CRC to receive an autologous tumor lysate dendritic cell vaccine plus … In patients with
metastatic melanoma, a phase I study … Phase II study of autologous tumor lysate-pulsed DC-CIK …

… lysate-pulsed DC vaccination, compared with unpulsed DC stimulation. … , as clinical benefit
relative to placebo is lower among patients with melanoma patients (more mutations) than …

… studies have focused on advanced CRC patients. In the present study, we reviewed 142
advanced colorectal cancer … of our study was to investigate whether advanced colorectal cancer …

… -stage cancers [34], including melanoma, follicular lymphoma, colorectal cancer, and non-small-cell
lung cancer… In conclusion, this research indicates that the combination of DC vaccine …